An analysis presented at IAS2024, HIV Pre-Exposure Prophylaxis Policies Worldwide, by the Georgetown University Center for Global Health Policy & Politics has found 69% of 194 countries reviewed have approved at least one PrEP product. But only 52% of the countries reviewed follow WHO guidance on PrEP eligibility with regulatory approvals and national policies that support PrEP eligibility for all populations or people at risk.
HIV Pre-Exposure Prophylaxis Policies Worldwide
Call for Applications for AVAC Advocacy Fellows
A flyer to share with your networks encouraging qualified applicants to reach out. More information about the AVAC Advocacy Fellows program available at avac.org/fellows.
Ugandan Service Provider Perspectives on the WHO Recommendation on Hormonal Contraceptives and HIV Risk
This abstract poster, developed by 2012 AVAC Advocacy Fellow Lydia Mulwanyi-Mukombe and her Host, Lillian Mworeko, describes key findings from consultations with Uganda service providers. It reports how providers were planning to use the new WHO guidance and makes recommendations for how to protect and inform women in light of the potential HIV risk associated with hormonal contraceptive use.
Taking it to the Streets: Engaging in-country stakeholders to plan for possible PrEP implementation
A poster presentation that goes through the steps advocates need to prepare their local community for PrEP.